Literature DB >> 7120117

Physiologic effects and plasma kinetics of beta-phenylethylamine and its N-methyl homolog in the dog.

H E Shannon, E J Cone, D Yousefnejad.   

Abstract

Single i.v. doses of beta-phenylethylamine (PEA) and its N-methyl homolog (NMPEA) were administered to separate groups of five dogs. The dose- and time-related effects of these compounds were determined on pupil diameter, heart rate and body temperature. Blood samples were obtained concurrently with the physiologic measures and plasma levels of PEA and NMPEA were determined by gas chromatography. Both compounds dilated pupils, tended to produce an initial tachycardia followed by a bradycardia and elevated body temperature. The plasma pharmacokinetics of both PEA and NMPEA could be described by first-order kinetics which estimated half-lives of approximately 5 to 10 min. Plasma levels for both amines correlated significantly only with increases in pupil diameter. The present findings demonstrate that the endogenous trace amine PEA and NMPEA, which may be produced enzymatically by nonspecific N-methyl transferases, produce prominent physiologic effects of short duration when administered i.v. in the dog, suggesting that alterations in the metabolism of these amines which result in elevated plasma levels can produce pronounced effects on mammalian nervous system function.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7120117

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Cerebral cortical blood flow maps are reorganized in MAOB-deficient mice.

Authors:  O U Scremin; D P Holschneider; K Chen; M G Li; J C Shih
Journal:  Brain Res       Date:  1999-04-03       Impact factor: 3.252

2.  β-phenylethylamine, a small molecule with a large impact.

Authors:  Meredith Irsfeld; Matthew Spadafore; Birgit M Prüß
Journal:  Webmedcentral       Date:  2013-09-30

3.  TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.

Authors:  Florent G Revel; Jean-Luc Moreau; Raul R Gainetdinov; Amyaouch Bradaia; Tatyana D Sotnikova; Roland Mory; Sean Durkin; Katrin Groebke Zbinden; Roger Norcross; Claas A Meyer; Veit Metzler; Sylvie Chaboz; Laurence Ozmen; Gerhard Trube; Bruno Pouzet; Bernhard Bettler; Marc G Caron; Joseph G Wettstein; Marius C Hoener
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-27       Impact factor: 11.205

4.  Reinforcing effects of phenethylamine analogs found in dietary supplements.

Authors:  Shelby A McGriff; Michael R Chojnacki; Eric B Thorndike; Kenner C Rice; Michael H Baumann; Charles W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2022-10-03       Impact factor: 4.415

Review 5.  Trace amine-associated receptor 1-Family archetype or iconoclast?

Authors:  David K Grandy
Journal:  Pharmacol Ther       Date:  2007-07-17       Impact factor: 12.310

6.  Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine.

Authors:  G B Baker; R T Coutts; T S Rao
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

7.  [14C]-beta-phenethylamine, its distribution after administration by various routes to cats, and the effects of monoamine oxidase inhibitors.

Authors:  G Garcha; P R Imrie; E Marley; D V Thomas
Journal:  Br J Pharmacol       Date:  1985-12       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.